These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 17113187)
1. Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab. Hassan AS; Kaelin U; Braathen LR; Yawalkar N J Am Acad Dermatol; 2007 Feb; 56(2):217-21. PubMed ID: 17113187 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment of severe refractory atopic dermatitis with efalizumab. Farshidi A; Sadeghi P J Drugs Dermatol; 2006; 5(10):994-8. PubMed ID: 17373150 [TBL] [Abstract][Full Text] [Related]
3. Efalizumab for severe atopic dermatitis: a pilot study in adults. Takiguchi R; Tofte S; Simpson B; Harper E; Blauvelt A; Hanifin J; Simpson E J Am Acad Dermatol; 2007 Feb; 56(2):222-7. PubMed ID: 17097386 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab. Weinberg JM; Siegfried EC Arch Dermatol; 2006 May; 142(5):555-8. PubMed ID: 16702492 [No Abstract] [Full Text] [Related]
6. Therapeutic effects of Baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by dermatophagoides pteronyssinus. Yun MY; Yang JH; Kim DK; Cheong KJ; Song HH; Kim DH; Cheong KJ; Kim YI; Shin SC Int Immunopharmacol; 2010 Sep; 10(9):1142-8. PubMed ID: 20621172 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis. Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718 [TBL] [Abstract][Full Text] [Related]
8. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus. Tavakolpour S Dermatol Ther; 2016 Sep; 29(5):299. PubMed ID: 26800435 [No Abstract] [Full Text] [Related]
9. Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases. Ibler K; Dam TN; Gniadecki R; Kragballe K; Jemec GB; Agner T J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):837-9. PubMed ID: 19368612 [TBL] [Abstract][Full Text] [Related]
10. Novel immunological approaches in the treatment of atopic eczema. Belloni B; Andres C; Ollert M; Ring J; Mempel M Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):423-7. PubMed ID: 18769195 [TBL] [Abstract][Full Text] [Related]
11. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Cassano N; Loconsole F; Coviello C; Vena GA Int J Immunopathol Pharmacol; 2006; 19(1):237-40. PubMed ID: 16569363 [TBL] [Abstract][Full Text] [Related]
12. Treatment of recalcitrant atopic dermatitis with omalizumab. Lane JE; Cheyney JM; Lane TN; Kent DE; Cohen DJ J Am Acad Dermatol; 2006 Jan; 54(1):68-72. PubMed ID: 16384758 [TBL] [Abstract][Full Text] [Related]